New surgical technique for bladder tumors shows promise in small study
NCT ID NCT07259798
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two surgical methods for removing medium-sized bladder tumors (2-6 cm) in 50 patients. One method removes the tumor in one piece (en-bloc), while the other removes it in fragments (conventional). The goal was to see which method provides better tissue samples for diagnosis and potentially better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If en-bloc resection proves better, it could become the preferred surgical technique for removing medium-sized bladder tumors, improving diagnosis and reducing recurrence.
- What could go wrong
- This is a small, completed study with only 50 participants, so results may not apply to all patients. The comparison is about surgical technique, not a new treatment, so impact is limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Tumor diameter of 2-6 cm * Patients fit for spinal or general anesthesia Exclusion Criteria: * recurrent bladder tumours. * concomitant urothelial cancer of the upper urinary tract * metastatic bladder cancer
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Urinary bladder cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University
Cairo, Abbasia, 11566, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill target cancers with a specific gene flaw?
- Could an ALS drug clear the fog of chemo brain?
- Promising combo aims to shrink bladder tumors before surgery
- Engineered immune cells take aim at multiple cancers in early trial
- Bladder cancer patients may skip surgery with new drug combo
- New program aims to protect cancer Patients' hearts during treatment